Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HYPR
HYPR logo

HYPR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Hyperfine Inc (HYPR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
1.600
1 Day change
15.11%
52 Week Range
2.220
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Hyperfine Inc (HYPR) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's innovative Swoop® system is gaining adoption, analysts have raised price targets, and the stock shows positive momentum. Despite insider selling, the long-term growth potential and increasing adoption of its technology make it a solid investment opportunity.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. The RSI is at 76.748, suggesting the stock is nearing overbought territory but not yet signaling a reversal. Moving averages are converging, and the stock has broken through key resistance levels (R1: 1.582, R2: 1.649), showing strong upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
13

Positive Catalysts

  • Swoop® system adoption is increasing, with over 1,000 scans in U.S. hospitals.

  • Research highlights improved patient care and reduced MRI wait times.

  • Additional equipment purchases by hospitals and clinics indicate strong demand.

  • Analysts have raised price targets and maintained Buy ratings.

Neutral/Negative Catalysts

  • Insiders are selling shares, with a significant 6311.17% increase in selling activity over the last month.

  • No significant hedge fund activity, indicating neutral sentiment from institutional investors.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are positive on the stock. B. Riley raised the price target from $1.60 to $2, maintaining a Buy rating. BTIG initiated coverage with a Buy rating and a $2 price target, citing the innovative Swoop® system and its next-generation advancements.

Wall Street analysts forecast HYPR stock price to rise
1 Analyst Rating
Wall Street analysts forecast HYPR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.390
sliders
Low
2
Averages
2
High
2
Current: 1.390
sliders
Low
2
Averages
2
High
2
B. Riley
Yuan Zhi
NULL
to
Buy
upgrade
$2
AI Analysis
2026-05-13
Reason
B. Riley
Yuan Zhi
Price Target
$2
AI Analysis
2026-05-13
upgrade
NULL
to
Buy
Reason
B. Riley analyst Yuan Zhi raised the firm's price target on Hyperfine to $2 from $1.60 and keeps a Buy rating on the shares.
BTIG
Buy
initiated
$2
2026-04-29
Reason
BTIG
Price Target
$2
2026-04-29
initiated
Buy
Reason
BTIG initiated coverage of Hyperfine with a Buy rating and $2 price target. The company's Swoop System enables point-of-care brain MRI at the bedside, expanding access to MRI imaging by eliminating the need for a shielded room, specialized staff, and patient transport, and the next-generation Swoop V2, cleared in May 2025, paired with the 11th-generation Optive AI software release in December 2025, offers a significant step forward in image quality and clinical utility, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HYPR
Unlock Now

People Also Watch